✦ LIBER ✦

Metastatic involvement of the stomach by breast cancer

✍ Scribed by Sung Ho Choi; F. Richard Sheehan; John W. Pickren

Publisher: John Wiley and Sons
Year: 1964
Tongue: English
Weight: 781 KB
Volume: 17
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(196406)17:6<791::aid-cncr2820170617>3.0.co;2-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The biology of metastatic breast cancer

✍ Janet E. Price 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 928 KB

Cancers metastatic to the breast

✍ Steven I. Hajdu; Jerome A. Urban 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 717 KB

Etoposide in the management of metastati

Etoposide in the management of metastatic breast cancer

✍ George W. Sledge Jr 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB 👁 2 views

Treatment of metastatic breast cancer wi

Treatment of metastatic breast cancer with aminoglutethimide

✍ R. F. Asbury; R. F. Bakemeier; E. Fölsch; C. S. McCune; E. Savlov; J. M. Bennett 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

Bilateral adrenalectomy in the palliatio

Bilateral adrenalectomy in the palliation of metastatic breast cancer

✍ Mortimer B. Lipsett; Willet F. Whitmore Jr.; Norman Treves; Charles D. West; Hen 📂 Article 📅 1957 🏛 John Wiley and Sons 🌐 English ⚖ 814 KB

Oral medroxyprogesterone in the treatmen

Oral medroxyprogesterone in the treatment of metastatic breast cancer

✍ Takuma Nemoto; Jashbha1 Patel; Dutzu Rosner; Thomas L. Dao 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB

In 47 postmenopausal women with evaluable breast cancer, oral medroxyprogesterone acetate (MPA) was given at a daily dose level of 400 mg. Patients with negative estrogen receptors, poor performance status , or nonresponse to previous endocrine therapy were excluded from this study. There were 25 (